ARROWHEAD PHARMACEUTICALS
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
ARROWHEAD PHARMACEUTICALS
Industry:
Biotechnology Health Care Nanotechnology Pharmaceutical
Founded:
1989-01-01
Address:
Pasadena, California, United States
Country:
United States
Website Url:
http://www.arrowheadpharma.com
Total Employee:
501+
Status:
Active
Contact:
(626) 304-3400
Email Addresses:
[email protected]
Total Funding:
899.88 M USD
Technology used in webpage:
Domain Not Resolving Euro IPv6 Cloudflare Hosting Microsoft Microsoft Azure Akamai Hosted Microsoft Azure US North Region
Similar Organizations
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Artivion
Artivion is a biological medical device company, which has been focused on the development of implantable biological.
Windtree Therapeutics
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Exscientia
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
LifeLens Technologies
LifeLens Technology is a biotechnology company that leads in innovative next generation treatment devices for personal health monitoring.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Telix Pharmaceuticals
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Zealand Pharma
Zealand Pharma is a biotechnology company that offers scientific expertise in turning peptides into medicines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silence Therapeutics
Silence Therapeutics investment in Post-IPO Equity - Arrowhead Pharmaceuticals
OrbiMed
OrbiMed investment in Post-IPO Equity - Arrowhead Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Arrowhead Pharmaceuticals
York Capital Management
York Capital Management investment in Post-IPO Equity - Arrowhead Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2011-01-18 | Calando Pharmaceuticals | Arrowhead Pharmaceuticals investment in Venture Round - Calando Pharmaceuticals | 1000 K USD |
| 2006-04-04 | Calando Pharmaceuticals | Arrowhead Pharmaceuticals investment in Venture Round - Calando Pharmaceuticals | 10 M USD |
Official Site Inspections
http://www.arrowheadpharma.com Semrush global rank: 1.56 M Semrush visits lastest month: 15.24 K
Unable to get host informations!!!
More informations about "Arrowhead Pharmaceuticals"
About Us | Arrowhead Pharmaceuticals
Learn more about Arrowhead Pharmaceutical's foundation as a therapeutic discovery company, innovative use of RNAi, and ambitious pipeline for developing medicines.See details»
Arrowhead Pharmaceuticals - Wikipedia
Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California.See details»
Arrowhead Pharmaceuticals - LinkedIn
At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat …See details»
Arrowhead Research Changes Name to Arrowhead Pharmaceuticals
[email protected] or Investor. Relations: The Trout Group Chad Rubin 646-378-2947 [email protected] or Media: Russo. Partners Matt Middleman, M.D. 212-845-4272 …See details»
Investors | Arrowhead Pharmaceuticals Inc.
Nov 18, 2024 The Investor Relations website contains information about Arrowhead Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
Sep 30, 2024 Target the gene, silence the disease. - Conference Call and Webcast Today, November 26, 2024, at 4:30 p.m. ET PASADENA, Calif.--(BUSINESS WIRE)--Nov. 26, 2024-- …See details»
Our Pipeline | Arrowhead Pharmaceuticals
Check out the development of Arrowhead’s products to treat challenging cardiometabolic, pulmonary, neuromuscular, liver, and more types of diseases.See details»
Arrowhead Pharmaceuticals - Crunchbase Company Profile
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin. Arrowhead Pharmaceuticals has experienced …See details»
Press Release Details - ir.arrowheadpharma.com
Nov 18, 2024 Arrowhead is committed to bringing new investigational medicines to patients with serious diseases as quickly and efficiently as possible. The company has established an …See details»
Arrowhead Pharmaceuticals Announces Global License and …
5 days ago Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). Upon …See details»
Arrowhead Pharmaceuticals Announces Global License and …
5 days ago Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT). Upon …See details»
Takeda and Arrowhead Collaborate to Co-Develop and Co …
Oct 8, 2020 “This agreement also supports our strategy of using partnering selectively to continue to invest in our Targeted RNAi Molecule (TRiM TM) platform and the growing pipeline …See details»
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
Feb 6, 2024 Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.See details»
Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter …
Jun 30, 2023 Conference Call and Webcast Today, August 7, 2023 at 4:30 p.m. ET PASADENA, Calif.--(BUSINESS WIRE)--Aug. 7, 2023-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: …See details»
Press Release Details - Arrowhead Pharmaceuticals Inc.
Aug 21, 2024 Arrowhead is committed to bringing new investigational medicines to patients with serious diseases as quickly and efficiently as possible. The company has established an early …See details»
Arrowhead Pharmaceuticals Inc: Overview - GlobalData
Up-to-date Arrowhead Pharmaceuticals Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Partnerships | Arrowhead Pharmaceuticals
Arrowhead actively engages in collaboration and licensing agreements with leading biotechnology and pharmaceutical companies to advance the development and commercialization of our …See details»
Arrowhead Pharmaceuticals Announces Planned Management …
Nov 15, 2019 PASADENA, Calif.--(BUSINESS WIRE)--Nov. 15, 2019-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Bruce Given, M.D., …See details»
Arrowhead Research Changes Name to Arrowhead Pharmaceuticals
Apr 6, 2016 As part of this name change, the company has also launched a new corporate website at www.arrowheadpharma.com and a new Twitter handle @ArrowheadPharma.See details»